<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Anesthesiol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Anesthesiol</journal-id><journal-title-group><journal-title>BMC Anesthesiology</journal-title></journal-title-group><issn pub-type="epub">1471-2253</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11863428</article-id><article-id pub-id-type="publisher-id">2975</article-id><article-id pub-id-type="doi">10.1186/s12871-025-02975-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Impact of perioperative anticoagulation management on free flap survival in reconstructive surgery: a retrospective analysis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Torabi</surname><given-names>Saeed</given-names></name><address><email>saeed.torabi@uk-koeln.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Overbeek</surname><given-names>Remco</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dusse</surname><given-names>Fabian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Stoll</surname><given-names>Sandra E.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Schroeder</surname><given-names>Carolin</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Zinser</surname><given-names>Max</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Zirk</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rcxh774</institution-id><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>Department of Anesthesiology and Intensive Care Medicine, Faculty of Medicine, </institution><institution>University Hospital Cologne, University of Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05mxhda18</institution-id><institution-id institution-id-type="GRID">grid.411097.a</institution-id><institution-id institution-id-type="ISNI">0000 0000 8852 305X</institution-id><institution>Department for Oral and Craniomaxillofacial and Plastic Surgery, Faculty of Medicine, </institution><institution>University Hospital Cologne, University of Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05mxhda18</institution-id><institution-id institution-id-type="GRID">grid.411097.a</institution-id><institution-id institution-id-type="ISNI">0000 0000 8852 305X</institution-id><institution>Department of Plastic, Reconstructive and Aesthetic Surgery, Faculty of Medicine, </institution><institution>University Hospital Cologne, University of Cologne, </institution></institution-wrap>Cologne, Germany </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>25</volume><elocation-id>106</elocation-id><history><date date-type="received"><day>15</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>14</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par6">Despite advancements in surgical techniques and perioperative care for free flap reconstructive surgery, concerns persist regarding the risk of free flap failure, with thrombosis and bleeding being the most common complications that can lead to flap loss. While perioperative anticoagulation management is crucial for optimizing outcomes in free flap reconstructive surgery, standardized protocols remain lacking. This study aims to investigate the role of anticoagulation and perioperative practices in free flap reconstructive surgery and their impact on surgical outcomes.</p></sec><sec><title>Methods</title><p id="Par7">This retrospective, single-center study included all adult patients undergoing free flap surgery from 2009 to 2020. Patients were retrospectively divided based on intraoperative (UFH or no UFH) and postoperative anticoagulation management (UFH only, Aspirin and UFH, Aspirin only). The relationship between anticoagulation protocols, PTT values, and flap survival was assessed.</p></sec><sec><title>Results</title><p id="Par8">A total of 489 free flap surgeries were included. Most flaps were taken from the upper extremity (49.5%), primarily for tumor-related reconstructions (85.7%). Flap loss occurred in 14.5% of cases, with a median time to flap loss of 3&#x000a0;days post-surgery. Intraoperative UFH (20&#x000a0;IU/kg) was administered to 63.6% of patients and significantly predicted flap survival (OR&#x02009;=&#x02009;0.45, 95% CI [0.24, 0.82]). PTT values on day 1 post-surgery were significantly related to flap survival (P&#x02009;=&#x02009;0.03), with each unit increase reducing the relative probability of flap loss by 5.2%. There was no significant difference in flap survival between patients treated with heparin alone and those treated with both heparin and aspirin. The small sample size in the aspirin-only group limited the statistical relevance of this subgroup.</p></sec><sec><title>Conclusion</title><p id="Par9">Our findings highlight the importance of intraoperative UFH and PTT-guided postoperative management in improving free flap survival. Standardized anticoagulation protocols are essential for enhancing outcomes in free flap reconstructive surgery.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Free flap surgery outcome</kwd><kwd>Perioperative Anticoagulation&#x000a0;management</kwd><kwd>Intraoperative heparin Administration</kwd><kwd>Postoperative PTT-Guided Anticoagulation</kwd><kwd>Microvascular Surgery Complications</kwd></kwd-group><funding-group><award-group><funding-source><institution>Universit&#x000e4;tsklinikum K&#x000f6;ln (8977)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par10">Free flap transplantation has become a standard and reliable reconstructive procedure for addressing soft tissue and bone defects in head and neck surgery for trauma or cancer, achieving success rates of approximately 95% [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. To support these outcomes standardized perioperative care measures have been incorporated into Enhanced Recovery after Surgery (ERAS) protocols [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>] with additional focus on intra-operative and post-operative physiological support [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref>]. Since the initial establishment of free flap reconstructive surgery in 1972 [<xref ref-type="bibr" rid="CR9">9</xref>], various perioperative predictors have been analysed as crucial for successful free flap transplantation, including perioperative anticoagulation therapy [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par11">Despite advancements in both surgical technique and perioperative care, concerns persist regarding the risk of free flap failure [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], with thrombosis and bleeding being the most common complications leading to flap loss [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Although various therapy protocols have been proposed [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR17">17</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>], a standardized approach of perioperative anticoagulation management is still lacking [<xref ref-type="bibr" rid="CR12">12</xref>]. Previous studies show contradictory results [<xref ref-type="bibr" rid="CR20">20</xref>]: while some do not attribute any benefit to postoperative anticoagulant administration [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], others demonstrate positive outcomes [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par12">Perioperative thromboprophylaxis is particularly critical in head and neck microvascular reconstruction, where patients face a heightened risk of venous thrombosis [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. However, the choice of anticoagulant remains debated [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR24">24</xref>], underscoring the need for further research to optimize management strategies for hypercoagulable states in microsurgical patients [<xref ref-type="bibr" rid="CR4">4</xref>]. While success rates in microvascular free tissue transfer are high [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], the lack of consensus on antithrombotic agents highlights the need for evidence-based guidelines in this field.</p><p id="Par13">This study aims to investigate the role of anticoagulation and perioperative antithrombotic practices in free flap reconstructive surgery. Our objective is to contribute to the ongoing discourse on standardized and optimized perioperative anticoagulation management in free flap surgery, with the ultimate goal of improving long-term outcomes.</p></sec><sec id="Sec2"><title>Materials and methods</title><p id="Par14">This study is a retrospective, single centre study at the University Hospital Cologne in Germany. Included in this study are all adult patients who underwent microvascular flap transplantation at the Center for Dental, Oral, and Maxillofacial Medicine of the University of Cologne between the years 2009&#x02013;2020. Patients were excluded in case of intra- or postoperative demise before flap healing.</p><sec id="Sec3"><title>Ethical approval</title><p id="Par15">The study protocol was approved by the institutional ethics committee of the University of Cologne. (Approval Nr. 24&#x02013;1305)</p></sec><sec id="Sec4"><title>Data Collection and Review</title><p id="Par16">Patient data for this study, including demographics, comorbidities, length of ICU / hospital length of stay and discharge information were retrospectively collected from the electronic hospital information system (ORBIS), OPS (operating procedure scores) codes and paper medical records using a standardized case report form. Data on diagnosis, defect localization, flap type, site and duration of surgery were also collected. Data collection encompassed a thorough review of intraoperative anesthesia protocols and postoperative patient records. Missing data were addressed as follows: patients with incomplete or missing critical information pertinent to the primary or secondary outcomes (e.g., details on intraoperative anticoagulation or postoperative PTT values) were excluded from the analysis. This approach was implemented to maintain the accuracy and reliability of the statistical models. Specifically, 140 cases were excluded due to insufficient documentation, resulting in a final dataset of 349 patients with complete records for analysis (Table <xref rid="Tab3" ref-type="table">3</xref>). To assess the effect of intraoperative anticoagulation, patients were retrospectively divided into two groups based on whether heparin was administered during surgery. Additionally, all patients were retrospectively divided into three groups based on their postoperative anticoagulation regimen: 1) Heparin, 2) Heparin + Aspirin, and 3) Aspirin only (100mg/ day). The decision on intraoperative and postoperative anticoagulation therapy was made by the attending surgeon at the time and didn&#x02019;t follow a given protocol. Postoperative administration of unfractionated heparin was initiated with an infusion pump (25000 IU/50 ml) at an initial dose of 500 IU/h, followed by PTT-controlled dosing every four hours for the first three days. Partial thromboplastin time (PTT) values for these first three days, along with the thrombocyte count, were also assessed (Table <xref rid="Tab4" ref-type="table">4</xref>).</p></sec><sec id="Sec5"><title>Statistics</title><p id="Par17">The collected patient data were initially entered into an Excel spreadsheet and numerically coded. IBM SPSS Statistics for Mac Version 27.0 (Statistical analysis software by IBM, SPSS Inc., U.S.A.) was used for statistical analysis. Categorical variables were examined for their frequencies and percentages, and metric variables for their means (standard deviation) and medians (interquartile ranges) depending on their distribution. Nominal parameters were examined for significance using cross-tabulations with Chi-square, Fisher's exact test or the Monte Carlo Simulation. Logistic regression analysis was performed on the categorical variables found significant in the cross-tabulations. Metric variables were analysed using the student&#x02019;s t-test or the Mann-Whitney-U-Test. Metric variables were also examined for their influence on flap survival using logistic regression. The prerequisites for conducting logistic regression were examined using the Box-Tidwell method. Additionally, the models were checked for multicollinearity to prevent correlation among individual variables. Statistical significance was considered at <italic>p</italic>-value &#x0003c; 0.05.</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>General findings</title><p id="Par18">From 2009 to 2020, a total of 489 free flap surgeries could be included in this study. Of all patients, 53,8% were male, and the median age was 62&#x000a0;years (IR 53.8&#x02013;72&#x000a0;years). A total of 71 free flap surgeries resulted in flap loss (14.5%). Median time of flap loss was day 3 after surgery (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). There was no significant relationship between age, sex, or comorbidities of the patient and flap loss (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Time of flap loss (days after surgery)</p></caption><graphic xlink:href="12871_2025_2975_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Demographic data and comorbidities. PAD: peripheral arterial disease</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Variable</th><th align="left">Total</th><th align="left">Flap loss</th><th align="left">Flap survival</th><th align="left"><italic>p</italic></th></tr><tr><th align="left"><italic>n</italic>&#x02009;=&#x02009;489</th><th align="left"><italic>n</italic>&#x02009;=&#x02009;71</th><th align="left"><italic>n</italic>&#x02009;=&#x02009;418</th><th align="left"/></tr></thead><tbody><tr><td align="left">Age (years)</td><td align="left">62 (53.8&#x02013;72)</td><td align="left">61 (52&#x02013;70)</td><td align="left">62 (54&#x02013;72)</td><td char="." align="char"><italic>P</italic>&#x02009;=&#x02009;0.36</td></tr><tr><td align="left">Sex (male)</td><td align="left">263 (53,8%)</td><td align="left">42 (59.2)</td><td align="left">221 (52.9)</td><td char="." align="char"><italic>P</italic>&#x02009;=&#x02009;0.33</td></tr><tr><td align="left"><bold>Comorbidities</bold></td><td align="left"><italic>(484)</italic></td><td align="left"><italic>(71)</italic></td><td align="left"><italic>(413)</italic></td><td char="." align="char"/></tr><tr><td align="left">Hypertension</td><td align="left">195 (40.3%)</td><td align="left">29 (40.9%)</td><td align="left">166 (40.2%)</td><td char="." align="char"><italic>P</italic>&#x02009;=&#x02009;0.92</td></tr><tr><td align="left">PAD</td><td align="left">28 (5.8%)</td><td align="left">6 (8.5%)</td><td align="left">22 (5.3%)</td><td char="." align="char"><italic>P&#x02009;</italic>=&#x02009;0.32</td></tr><tr><td align="left">Nicotine history</td><td align="left">97 (20%)</td><td align="left">15 (21.1%)</td><td align="left">82 (19.9%)</td><td char="." align="char"><italic>P</italic>&#x02009;=&#x02009;0.81</td></tr><tr><td align="left">Diabetes mellitus</td><td align="left">67 (13.8%)</td><td align="left">8 (11.3%)</td><td align="left">59 (14.3%)</td><td char="." align="char"><italic>P</italic>&#x02009;=&#x02009;0.50</td></tr></tbody></table></table-wrap></p><p id="Par19">Most free flaps were taken from the upper extremity (49.5%), and the main reason for requiring a reconstructive flap surgery was a tumour (85.7%). The location of the defect was intraoral in 72.3% of patients (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). The type of defect, localization of the defect, and origin of the flap were all significantly related to the probability of a perioperative flap loss (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Surgeries more often resulted in flap loss when the defect localization and the flap origin were in the lower extremity. Conversely, surgeries performed intraorally, and flaps taken from the upper extremity were more likely to result in flap survival. (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). The relation between duration of the surgery and flap loss was also statistically significant (P&#x02009;&#x0003c;&#x02009;0.001) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).
<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Perioperative diagnosis, localization of defect, type of defect, origin of flap and time of surgery related to flap loss. The p-values marked with an * were calculated using the Monte-Carlo method</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Variable</th><th align="left">Total</th><th align="left">Flap loss</th><th align="left">Flap survival</th><th align="left"><italic>p</italic></th></tr><tr><th align="left"><italic>n</italic>&#x02009;=&#x02009;489</th><th align="left"><italic>n&#x02009;</italic>=&#x02009;71</th><th align="left"><italic>n</italic>&#x02009;=&#x02009;418</th><th align="left"/></tr></thead><tbody><tr><td align="left">Diagnosis</td><td align="left"><italic>(489)</italic></td><td align="left"><italic>(71)</italic></td><td align="left"><italic>(418)</italic></td><td align="left"/></tr><tr><td align="left">Tumour</td><td align="left">419 (85.7%)</td><td align="left">51 (71.8%)</td><td align="left">368 (88%)</td><td align="left">P&#x02009;&#x0003c;&#x02009;0.01</td></tr><tr><td align="left">Infection</td><td align="left">15 (3.1%)</td><td align="left">5 (7%)</td><td align="left">19 (4.6%)</td><td align="left">P&#x02009;=&#x02009;0.06</td></tr><tr><td align="left">Trauma</td><td align="left">19 (3.9%)</td><td align="left">4 (5.6%))</td><td align="left">15 (3.6%)</td><td align="left">P&#x02009;=&#x02009;0.43</td></tr><tr><td align="left">Other</td><td align="left">35 (7.2%)</td><td align="left">11(15.5%)</td><td align="left">24 (5.7%)</td><td align="left">P&#x02009;&#x0003c;&#x02009;0.01</td></tr><tr><td align="left">Localization of defect</td><td align="left"><italic>(488)</italic></td><td align="left"><italic>(71)</italic></td><td align="left"><italic>(417)</italic></td><td align="left"/></tr><tr><td align="left">Intraoral</td><td align="left">353 (72.3%)</td><td align="left">43 (60.6%)</td><td align="left">310 (74.3%)</td><td align="left"/></tr><tr><td align="left">Head/Neck</td><td align="left">50 (10.2%)</td><td align="left">12 (17%)</td><td align="left">38 (9.1%)</td><td align="left"/></tr><tr><td align="left">Arm</td><td align="left">7 (1.4%)</td><td align="left">0 (0%)</td><td align="left">7 (1.7%)</td><td align="left">P*&#x02009;&#x0003c;&#x02009;0.01</td></tr><tr><td align="left">Leg</td><td align="left">49 (10%)</td><td align="left">16 (22.5%)</td><td align="left">33 (7.9%)</td><td align="left"/></tr><tr><td align="left">Thorax</td><td align="left">29 (5.9%)</td><td align="left">0 (0%)</td><td align="left">29 (7%)</td><td align="left"/></tr><tr><td align="left">Defect</td><td align="left"><italic>(488)</italic></td><td align="left"><italic>(70)</italic></td><td align="left"><italic>(418)</italic></td><td align="left"/></tr><tr><td align="left">Soft tissue</td><td align="left">377 (77.3%)</td><td align="left">54 (77.1%)</td><td align="left">323 (77.3%)</td><td align="left"/></tr><tr><td align="left">Bone</td><td align="left">2 (0,4%)</td><td align="left">1(1.4%)</td><td align="left">1 (0.2%)</td><td align="left">P*&#x02009;=&#x02009;0.42</td></tr><tr><td align="left">Bone and soft tissue</td><td align="left">109 (22.3%)</td><td align="left">15 (21.4%)</td><td align="left">94 (22.5%)</td><td align="left"/></tr><tr><td align="left">Origin of Flap</td><td align="left">(489)</td><td align="left">(71)</td><td align="left">(418)</td><td align="left"/></tr><tr><td align="left">Abdomen</td><td align="left">27 (5.5%)</td><td align="left">1 (1.4%)</td><td align="left">26 (6.2%)</td><td align="left"/></tr><tr><td align="left">Arm</td><td align="left">242 (49.5%)</td><td align="left">25 (35.2%)</td><td align="left">217 51.9%)</td><td align="left">P*&#x02009;=&#x02009;0.01</td></tr><tr><td align="left">Leg</td><td align="left">173 (35.4%)</td><td align="left">40 (56.3%)</td><td align="left">133 (31.8%)</td><td align="left"/></tr><tr><td align="left">Thorax</td><td align="left">47 (9.6%)</td><td align="left">5 (7%)</td><td align="left">42 (10%)</td><td align="left"/></tr><tr><td align="left">Time of surgery (minutes)</td><td align="left">492.5 (144.9)</td><td align="left">579.4 (183.8)</td><td align="left">477.1 (131)</td><td align="left">P&#x02009;&#x0003c;&#x02009;0.01</td></tr></tbody></table></table-wrap><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Duration of surgery (minutes) and flap loss</p></caption><graphic xlink:href="12871_2025_2975_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec8"><title>Influence of anticoagulation on flap survival</title><p id="Par20">63,6% of our patients received intravenous unfractionated heparin intraoperatively (20 IU/kg). There was a significant relationship between flap survival and the administration of heparin during surgery (P=0.01) (Table <xref rid="Tab3" ref-type="table">3</xref>). The binomial logistic regression model was also statistically significant, &#x003c7;<sup>2</sup>(<italic>1</italic>) = 7.70, p = 0.01, with Nagelkerke's R<sup>2</sup> = 0.04. The classification accuracy was 85.9%. The use of intraoperative heparin significantly predicted flap survival (p = 0.01) with an odds ratio (OR) of 0.45 (95% CI [0.24, 0.82]).</p><p id="Par21">The low Nagelkerke's R<sup>2</sup> values observed in our logistic regression models indicate that while the identified variables (intraoperative heparin administration, PTT values on postoperative day 1) show statistically significant associations with flap survival, they explain only a small proportion of the variability in the outcome. This suggests that other unmeasured factors, such as surgical technique, patient-specific characteristics may also play a critical role in determining flap survival.</p><p id="Par22">There was no significant difference in flap survival between patients treated with heparin alone and those treated with both heparin and aspirin. Aspirin without additional heparin was used in only three patients, with flap loss occurring in two of these cases.
<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Intraoperative and postoperative anticoagulation therapy and influence on flap survival</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Anticoagulation regime</th><th align="left">Total</th><th align="left">Flap loss</th><th align="left">Flap survival</th><th align="left"><italic>p</italic></th></tr></thead><tbody><tr><td align="left"/><td align="left"><italic>349</italic></td><td align="left"><italic>49</italic></td><td align="left"><italic>300</italic></td><td char="." align="char"/></tr><tr><td align="left">Intraoperative Heparin</td><td align="left">222 (63.6%)</td><td align="left">23 (46.9%)</td><td align="left">199 (66.3%)</td><td char="." align="char">P&#x02009;=&#x02009;0.01</td></tr><tr><td align="left">Postoperative anticoagulation</td><td align="left"><italic>342</italic></td><td align="left"><italic>51</italic></td><td align="left"><italic>291</italic></td><td char="." align="char"/></tr><tr><td align="left">Aspirin</td><td align="left">3 (0.3%)</td><td align="left">2 (3.9%)</td><td align="left">1 (0.3%)</td><td char="." align="char">P&#x02009;=&#x02009;0.06</td></tr><tr><td align="left">Heparin</td><td align="left">261 (74.8%)</td><td align="left">38 (74.5%)</td><td align="left">223 (76.6%)</td><td char="." align="char">P&#x02009;=&#x02009;0.74</td></tr><tr><td align="left">Aspirin&#x02009;+&#x02009;Heparin</td><td align="left">67 (19.6%)</td><td align="left">10 (19.6%)</td><td align="left">57 (19.6%)</td><td char="." align="char">P&#x02009;=&#x02009;0.99</td></tr></tbody></table></table-wrap></p><p id="Par23">PTT values on the first day after surgery were significantly related to flap survival (P&#x02009;=&#x02009;0.03). PTT Values on days two and three were lower in patients who experienced flap loss, though these differences were not statistically significant (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Logistic regression analysis for day one values indicated that the model (&#x003c7;<sup>2</sup>(<italic>1</italic>)&#x02009;=&#x02009;6.06, p&#x02009;=&#x02009;0.01, Nagelkerke's R<sup>2</sup>&#x02009;=&#x02009;0.02, classification accuracy&#x02009;=&#x02009;85.7%) was statistically significant. For each unit increase in the pTT value on day one, the relative probability of flap loss decreased by 5.2%. There was no significant correlation between thrombocytes count and flap survival (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>).
<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Postoperative laboratory values. PTT: Partial thromboplastin time (second)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Variable</th><th align="left">Total</th><th align="left">Flap loss</th><th align="left">Flap survival</th><th align="left"><italic>p</italic></th></tr><tr><th align="left">n&#x02009;=&#x02009;489</th><th align="left">n&#x02009;=&#x02009;71</th><th align="left">n&#x02009;=&#x02009;418</th><th align="left"/></tr></thead><tbody><tr><td align="left">pTT day 1 (sec.)</td><td align="left">31.2 (7.7)</td><td align="left">29.3 (5.5)</td><td align="left">31.5 (8.0)</td><td char="." align="char">P&#x02009;=&#x02009;0.03</td></tr><tr><td align="left">pTT day 2 (sec.)</td><td align="left">35.5 (9.3)</td><td align="left">34.6 (8.7)</td><td align="left">35.4 (11.4)</td><td char="." align="char">P&#x02009;=&#x02009;0.59</td></tr><tr><td align="left">pTT day 3 (sec.)</td><td align="left">31.3 (7)</td><td align="left">30.6 (7.3)</td><td align="left">33.0 (8.7)</td><td char="." align="char">P&#x02009;=&#x02009;0.06</td></tr><tr><td align="left">&#x02003;Thrombocytes day 1 (10<sup>9</sup>/L)</td><td align="left">192.6 (69.7)</td><td align="left">199.0 (83.5)</td><td align="left">190.9 (67.3)</td><td char="." align="char">P&#x02009;=&#x02009;0.38</td></tr><tr><td align="left">&#x02003;Thrombocytes day 2 (10<sup>9</sup>/L)</td><td align="left">161.8 (57.5)</td><td align="left">169.3 (69.5)</td><td align="left">163.5 (56.9)</td><td char="." align="char">P&#x02009;=&#x02009;0.49</td></tr><tr><td align="left">&#x02003;Thrombocytes day 3 (10<sup>9</sup>/L)</td><td align="left">158.3 (57)</td><td align="left">165.9 (58)</td><td align="left">164.7 (61.4)</td><td char="." align="char">P&#x02009;=&#x02009;0.88</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec9"><title>Discussion</title><sec id="Sec10"><title>Summary of results</title><p id="Par24">Our study demonstrated that the application of intraoperative heparin had a positive impact on free flap survival. Moreover, no additional benefit from the combination of heparin and aspirin could be detected. Prolonged PTT levels on the first postoperative day were associated with increased rates of flap survival whereas prolonged PTT levels on the second or third postoperative day were not associated with a better flap outcome. All these findings were independent of age, BMI and preexisting comorbidities.</p><p id="Par25">However, we note that while intraoperative heparin uses and day-one PTT values are statistically significant in relation to flap survival, the low Nagelkerke's R<sup>2</sup> values may indicate a weak relationship to flap survival in logistic regression analysis. Despite the low R<sup>2</sup> values, the clinical relevance of our findings should not be underestimated. The statistically significant associations observed highlight key actionable factors that can guide perioperative management, such as the importance of intraoperative heparin administration and PTT-guided postoperative monitoring.</p><p id="Par26">Our study also found that free flap reconstruction of the lower extremity, compared to the upper extremity or enoral sites as well as an extended duration of the surgery was associated with a higher chance of flap loss.</p><p id="Par27">Contrary to our findings, Dawoud et al. [<xref ref-type="bibr" rid="CR16">16</xref>] showed that anticoagulation therapy led to increased flap loss. However, this meta-analysis, which included eight retrospective studies that often involved heterogeneous patients with different anticoagulation therapy protocols, should be critically evaluated. Barton&#x02019;s systematic review further illustrates the lack of consensus regarding anticoagulant protocols [<xref ref-type="bibr" rid="CR10">10</xref>]. The most commonly used agents for antithrombotic therapy were aspirin [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>] and low-dose heparin [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par28">Preoperative factors such as age and gender were not associated with flap loss in our patient group, a finding corroborated by other studies [<xref ref-type="bibr" rid="CR11">11</xref>]. Similarly, preexisting conditions such as arterial hypertension, peripheral artery disease (PAD), and diabetes mellitus showed no significant adverse impact on flap survival, consistent with previous studies [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. More decisive for therapeutic success are the localization of the defect and the origin of the flap. Consistent with widely accepted views in the literature, intraoral defects with radial forearm flaps showed the best outcomes [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>].</p></sec><sec id="Sec11"><title>Intraoperative management</title><p id="Par29">In our patient cohort, the intraoperative administration of unfractionated heparin at a dose of 20 IU/kg showed a significant advantage in terms of flap survival. A European study by Rendenbach et al. demonstrated the widespread intraoperative administration of heparin following free flap harvesting, although the dosage varied significantly, ranging from 500 IU to 10,000 IU [<xref ref-type="bibr" rid="CR12">12</xref>]. Other authors recommend the administration of aspirin intraoperatively and its continuation for three days postoperatively [<xref ref-type="bibr" rid="CR18">18</xref>]. However, given a recent meta-analysis that found no benefit from aspirin, this practice should be critically evaluated [<xref ref-type="bibr" rid="CR27">27</xref>].</p><p id="Par30">Another crucial parameter affecting surgical outcome is the duration of surgery [<xref ref-type="bibr" rid="CR29">29</xref>]. The prevailing opinion is that the duration of surgery should be as short as possible [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Chang et al. observed a negative effect on fibular flaps when the ischemia time exceeded 4 hours [<xref ref-type="bibr" rid="CR32">32</xref>]. In 2016, Fichter et al. published a series of 8 patients with fibula grafts, demonstrating a success rate of over 96% following extracorporeal perfusion to reduce ischemia time [<xref ref-type="bibr" rid="CR33">33</xref>].</p><p id="Par31">Patients' body temperatures were continuously monitored using temperature probes, and active warming was achieved through the use of a Bair Hugger warming system. Additionally, pre-warmed intravenous fluids were consistently used during fluid therapy to minimize the risk of hypothermia, particularly given the prolonged duration of these surgeries. These measures are critical in preventing hypothermia-induced coagulopathy, which could negatively impact flap survival.</p></sec><sec id="Sec12"><title>Postoperative management</title><p id="Par32">In literature, Rothweiler et al. divided complications into early and late phases, defining the first 72&#x000a0;h postoperatively as the critical phase. In our study, complications and flap loss peaked on the third postoperative day, also indicating a critical period within the first 72 hours [<xref ref-type="bibr" rid="CR18">18</xref>]. Other authors have made similar suggestions regarding early postoperative management [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Rothweiler recommends continuing aspirin (100&#x000a0;mg/day) at least during the early postoperative phase following an intraoperative loading dose of 300&#x000a0;mg and views UFH critically when administered at higher initial doses [<xref ref-type="bibr" rid="CR18">18</xref>]. A recent meta-analysis demonstrated that the administration of aspirin has no direct effect on flap survival [<xref ref-type="bibr" rid="CR27">27</xref>]. Our study also showed similar results, with no significant difference in flap survival between patients treated with heparin alone and those treated with both UFH and aspirin (100&#x000a0;mg/day). Therefore, the risk&#x02013;benefit assessment regarding bleeding complications following the administration of aspirin should be carefully considered.</p><p id="Par33">Contrary to this, we recommend intraoperative administration of UFH (20 IU/kg) instead and continuation of postoperative therapy with PTT-controlled UFH to minimize bleeding risk. While the postoperative administration of heparin has also been recommended by other authors [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], further analysis is needed to determine the optimal PTT target values for therapy management. While Rotweiler et al [<xref ref-type="bibr" rid="CR18">18</xref>] aimed for a PTT of 60&#x02013;80 seconds and noted increased bleeding rates with higher doses of UFH, we suggest targeting a PTT of 40&#x02013;60seconds [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par34">A comparable alternative to avoid frequent PTT monitoring is the administration of enoxaparin. Karimi et al [<xref ref-type="bibr" rid="CR15">15</xref>]. achieved similarly favourable results with a postoperative enoxaparin dosis of 40 mg/day, showing a short-term success rate of 100. However, their study included only 30 patients. Sievert et al compared postoperative UFH and LMWH, finding comparable hematoma and revision rates with both heparin options [<xref ref-type="bibr" rid="CR19">19</xref>]. Similarly, a meta-analysis by Dawoud et al. demonstrated comparable outcomes for postoperative administration of UFH and LMWH [<xref ref-type="bibr" rid="CR16">16</xref>]. Another risk factor for thrombosis is perioperative thrombocytosis, particularly in trauma patients [<xref ref-type="bibr" rid="CR37">37</xref>]. Kalmar et al [<xref ref-type="bibr" rid="CR38">38</xref>] identified platelet counts over 250 k/mcL as a risk factor for flap failure in breast reconstruction [<xref ref-type="bibr" rid="CR38">38</xref>]. We found no significant correlation between platelet counts during the first three postoperative days and flap failure.</p><p id="Par35">In summary, although various studies have introduced different strategies for managing anticoagulation therapy, a lack of consensus and clear guidelines persists. Additionally, patient-specific factors, particularly in an aging population, must be considered, such as anticoagulation therapy for patients with pre-existing atrial fibrillation.</p><p id="Par36">We also observe a continuously evolving approach to postoperative monitoring of transplanted flaps. Wax et al. demonstrated that intraoperative Doppler ultrasonography enhances the detection of immediate vascular complications, thereby reducing the need for subsequent revisions [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Zinser et al. further introduced advanced ultrasound techniques to assess the perfusion of already implanted flaps, indicating a significant advancement in postoperative care [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>].</p><p id="Par37">it is important to highlight that several factors contribute to the success of free flap surgeries and flap survival, as demonstrated in various studies [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. These factors include the duration of the surgery, preoperative radiation, the type of flap harvested, and the anastomosis technique employed. While our study focused primarily on anticoagulation, it is important to recognize that not only thrombotic events, which may lead to ischemia, and anastomotic insufficiencies are critical for flap viability, but haemorrhagic complications also play a significant role in the overall outcome.</p><p id="Par38">In conclusion, our findings emphasize the importance of a standardized perioperative anticoagulation protocol in free flap surgery. Specifically, the intraoperative administration of unfractionated heparin (UFH) at a dose of 20 IU/kg was shown to significantly improve flap survival and should be incorporated into routine practice. Postoperative management using PTT-guided UFH therapy, targeting a range of 40&#x02013;60 seconds during the first three days, offers an effective approach to balancing the risks of thrombosis and bleeding. Additionally, the absence of a significant benefit from combining UFH with aspirin suggests that aspirin may not be routinely necessary, simplifying the anticoagulation regimen for most patients while maintaining safety and efficacy.</p></sec><sec id="Sec13"><title>Limitations</title><p id="Par39">In our study, we aimed to analyse perioperative data from our patient cohort regarding anticoagulation therapy, addressing the current data gap and lack of guidelines for postoperative anticoagulation in patients undergoing flap transplantation.</p><p id="Par40">Limitations of our study include its retrospective nature and a highly diverse patient cohort with various flap types. Another limitation of our study was the absence of data for some patients, limiting the final analysis to 349 patients. Additionally, the sample size in group three, which received aspirin only, was small, preventing significant statistical findings. It is important to note that, due to lack of data such as antithrombin III levels, a complete picture of postoperative anticoagulation monitoring cannot be presented here. Furthermore, due to missing data, complications such as bleeding or thrombosis could not be adequately assessed.</p><p id="Par41">Another major limitation is the decision for anticoagulation regime, which was made by the attending surgeon based on individual preference and patient characteristics and the quality of anastomosis without a clear protocol. Given the discrepancies in published studies, we recommend a prospective multicenter study for future research.</p></sec></sec><sec id="Sec14"><title>Conclusions</title><p id="Par42">Despite the lack of consensus regarding perioperative anticoagulation therapy, we conclude that anticoagulation is essential for free flap preservation and surgical success. Based on our experience, a combined anticoagulation approach, with intraoperative heparin at 20 IU/kg followed by postoperative unfractionated heparin for the first three days, using a PTT-guided therapy with a predefined target range of 40&#x02013;60 seconds, as implemented in our clinic, represents an effective option for postoperative management. We were unable to identify any significant benefit from the supplementary administration of aspirin postoperatively.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>Not applicable.</p><sec id="FPar1"><title>Institutional review board statement</title><p id="Par43">The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the Medical Faculty of the University of Cologne (Reference No. 24-1305).</p></sec><sec id="FPar2"><title>Informed consent statement</title><p id="Par44">Patient consent was waived due to its retrospective design by the Ethics Committee of the Medical Faculty of the University of Cologne.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions
</title><p>Conceptualization: ST, FD; Investigation, ST, RO, SC; Supervision: MZ, FD, MZ; Writing&#x02014;original draft, ST, RO; Writing&#x02014;review and editing, ST, RO, FD, SS; All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL. We acknowledge support for the Article Processing Charge from the DFG (German Research Foundation, 491454339).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar3"><title>Consent for publication</title><p id="Par45">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par46">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References
</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Askari M, Fisher C, Weniger FG, al. et. Anticoagulation therapy in microsurgery: a review. J Hand Surg Am. 2006;31:836&#x02013;846.</mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Chien W, Varvares MA, Hadlock T, al. et. Effects of aspirin and low-dose heparin in head and neck reconstruction using microvascular free flaps. Laryngoscope. 2005;115:973&#x02013;976.</mixed-citation></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Batdorf</surname><given-names>NJ</given-names></name><name><surname>Lemaine</surname><given-names>V</given-names></name><name><surname>Lovely</surname><given-names>JK</given-names></name><etal/></person-group><article-title>Enhanced recovery after surgery in microvascular breast reconstruction</article-title><source>J Plast Reconstr Aesthet Surg</source><year>2015</year><volume>68</volume><issue>3</issue><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/J.BJPS.2014.11.014</pub-id><pub-id pub-id-type="pmid">25488326</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Batdorf NJ, Lemaine V, Lovely JK, et al. Enhanced recovery after surgery in microvascular breast reconstruction. J Plast Reconstr Aesthet Surg. 2015;68(3):395&#x02013;402. 10.1016/J.BJPS.2014.11.014.<pub-id pub-id-type="pmid">25488326</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Schr&#x000f6;der TA, Leonhardt H, Haim D, et al. Enhancing Anticoagulation Monitoring and Therapy in Patients Undergoing Microvascular Reconstruction in Maxillofacial Surgery: A Prospective Observational Trial. J Pers Med. 2022;12(8). 10.3390/jpm12081229.</mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Dort J, Farwell D, Findlay M, &#x02026; GH&#x02026; -head &#x00026; neck, 2017 undefined. Optimal perioperative care in major head and neck cancer surgery with free flap reconstruction: a consensus review and recommendations from the enhanced. jamanetwork.com. Accessed May 13, 2024. <ext-link ext-link-type="uri" xlink:href="https://jamanetwork.com/journals/jamaotolaryngology/article-abstract/2565537">https://jamanetwork.com/journals/jamaotolaryngology/article-abstract/2565537</ext-link>.</mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">Hagau N, the DLMOJ of, 2009 undefined. Anesthesia for free vascularized tissue transfer. Wiley Online LibraryN Hagau, DAN LongroisMicrosurgery: Official Journal of the International Microsurgical, 2009&#x02022;Wiley Online Library. 2008;29(2):161&#x02013;167. 10.1002/micr.20584.</mixed-citation></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>JS</given-names></name><name><surname>Desai</surname><given-names>SV</given-names></name><name><surname>Crippen</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Association of anesthesia duration with complications after microvascular reconstruction of the head and neck</article-title><source>JAMA Facial Plast Surg</source><year>2018</year><volume>20</volume><issue>3</issue><fpage>188</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1001/jamafacial.2017.1607</pub-id><pub-id pub-id-type="pmid">28983575</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Brady JS, Desai SV, Crippen MM, et al. Association of anesthesia duration with complications after microvascular reconstruction of the head and neck. JAMA Facial Plast Surg. 2018;20(3):188&#x02013;95. 10.1001/jamafacial.2017.1607.<pub-id pub-id-type="pmid">28983575</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>TJ</given-names></name><name><surname>Soppitt</surname><given-names>A</given-names></name><name><surname>Maroof</surname><given-names>M</given-names></name><etal/></person-group><article-title>Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery</article-title><source>Anesthesiology</source><year>2002</year><volume>97</volume><issue>4</issue><fpage>820</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1097/00000542-200210000-00012</pub-id><pub-id pub-id-type="pmid">12357146</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Gan TJ, Soppitt A, Maroof M, et al. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002;97(4):820&#x02013;6. 10.1097/00000542-200210000-00012.<pub-id pub-id-type="pmid">12357146</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>DH</given-names></name><name><surname>Buncke</surname><given-names>HJ</given-names></name></person-group><article-title>Autotransplant of omentum to a large scalp defect, with microsurgical revascularization</article-title><source>Plast Reconstr Surg</source><year>1972</year><volume>49</volume><issue>3</issue><fpage>268</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1097/00006534-197203000-00005</pub-id><pub-id pub-id-type="pmid">4551236</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">McLean DH, Buncke HJ. Autotransplant of omentum to a large scalp defect, with microsurgical revascularization. Plast Reconstr Surg. 1972;49(3):268&#x02013;74. 10.1097/00006534-197203000-00005.<pub-id pub-id-type="pmid">4551236</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname><given-names>BM</given-names></name><name><surname>Riley</surname><given-names>CA</given-names></name><name><surname>Fitzpatrick</surname><given-names>JC</given-names></name><name><surname>Hasney</surname><given-names>CP</given-names></name><name><surname>Moore</surname><given-names>BA</given-names></name><name><surname>McCoul</surname><given-names>ED</given-names></name></person-group><article-title>Postoperative anticoagulation after free flap reconstruction for head and neck cancer: A systematic review</article-title><source>Laryngoscope</source><year>2018</year><volume>128</volume><issue>2</issue><fpage>412</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1002/lary.26703</pub-id><pub-id pub-id-type="pmid">28581030</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Barton BM, Riley CA, Fitzpatrick JC, Hasney CP, Moore BA, McCoul ED. Postoperative anticoagulation after free flap reconstruction for head and neck cancer: A systematic review. Laryngoscope. 2018;128(2):412&#x02013;21. 10.1002/lary.26703.<pub-id pub-id-type="pmid">28581030</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>WB</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Risk factors for free flap failure: a retrospective analysis of 881 free flaps for head and neck defect reconstruction</article-title><source>Int J Oral Maxillofac Surg</source><year>2017</year><volume>46</volume><issue>8</issue><fpage>941</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1016/j.ijom.2017.03.023</pub-id><pub-id pub-id-type="pmid">28416356</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Zhou W, Zhang WB, Yu Y, et al. Risk factors for free flap failure: a retrospective analysis of 881 free flaps for head and neck defect reconstruction. Int J Oral Maxillofac Surg. 2017;46(8):941&#x02013;5. 10.1016/j.ijom.2017.03.023.<pub-id pub-id-type="pmid">28416356</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Rendenbach</surname><given-names>C</given-names></name><name><surname>H&#x000f6;lterhoff</surname><given-names>N</given-names></name><name><surname>Hischke</surname><given-names>S</given-names></name><etal/></person-group><article-title>Free flap surgery in Europe: an interdisciplinary survey</article-title><source>Int J Oral Maxillofac Surg</source><year>2018</year><volume>47</volume><issue>5</issue><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1016/j.ijom.2017.11.013</pub-id><pub-id pub-id-type="pmid">29275838</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Rendenbach C, H&#x000f6;lterhoff N, Hischke S, et al. Free flap surgery in Europe: an interdisciplinary survey. Int J Oral Maxillofac Surg. 2018;47(5):676&#x02013;82. 10.1016/j.ijom.2017.11.013.<pub-id pub-id-type="pmid">29275838</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Swartz</surname><given-names>JE</given-names></name><name><surname>Aarts</surname><given-names>MCJ</given-names></name><name><surname>Swart</surname><given-names>KMA</given-names></name><etal/></person-group><article-title>The value of postoperative anticoagulants to improve flap survival in the free radial forearm flap: A systematic review and retrospective multicentre analysis</article-title><source>Clin Otolaryngol</source><year>2015</year><volume>40</volume><issue>6</issue><fpage>600</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1111/COA.12425</pub-id><pub-id pub-id-type="pmid">25823832</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Swartz JE, Aarts MCJ, Swart KMA, et al. The value of postoperative anticoagulants to improve flap survival in the free radial forearm flap: A systematic review and retrospective multicentre analysis. Clin Otolaryngol. 2015;40(6):600&#x02013;9. 10.1111/COA.12425.<pub-id pub-id-type="pmid">25823832</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhard</surname><given-names>JP</given-names></name><name><surname>Pfister</surname><given-names>J</given-names></name><name><surname>Giger</surname><given-names>R</given-names></name><etal/></person-group><article-title>Perioperative predictors of early surgical revision and flap-related complications after microvascular free tissue transfer in head and neck reconstructions: a retrospective observational series</article-title><source>Clin Oral Investig</source><year>2021</year><volume>25</volume><issue>9</issue><fpage>5541</fpage><lpage>5550</lpage><pub-id pub-id-type="doi">10.1007/s00784-021-03864-1</pub-id><pub-id pub-id-type="pmid">33686470</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Burkhard JP, Pfister J, Giger R, et al. Perioperative predictors of early surgical revision and flap-related complications after microvascular free tissue transfer in head and neck reconstructions: a retrospective observational series. Clin Oral Investig. 2021;25(9):5541&#x02013;50. 10.1007/s00784-021-03864-1.<pub-id pub-id-type="pmid">33686470</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Karimi</surname><given-names>E</given-names></name><name><surname>Ardestani</surname><given-names>SHS</given-names></name><name><surname>Jafari</surname><given-names>M</given-names></name><name><surname>Hagh</surname><given-names>AB</given-names></name></person-group><article-title>Testing a New Anticoagulation Method for Free Flap Reconstruction of Head and Neck Cancers</article-title><source>Clin Exp Otorhinolaryngol</source><year>2016</year><volume>9</volume><issue>4</issue><fpage>370</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.21053/CEO.2015.01781</pub-id><pub-id pub-id-type="pmid">27337950</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Karimi E, Ardestani SHS, Jafari M, Hagh AB. Testing a New Anticoagulation Method for Free Flap Reconstruction of Head and Neck Cancers. Clin Exp Otorhinolaryngol. 2016;9(4):370&#x02013;3. 10.21053/CEO.2015.01781.<pub-id pub-id-type="pmid">27337950</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Dawoud</surname><given-names>BES</given-names></name><name><surname>Kent</surname><given-names>S</given-names></name><name><surname>Tabbenor</surname><given-names>O</given-names></name><name><surname>Markose</surname><given-names>G</given-names></name><name><surname>Java</surname><given-names>K</given-names></name><name><surname>Kyzas</surname><given-names>P</given-names></name></person-group><article-title>Does anticoagulation improve outcomes of microvascular free flap reconstruction following head and neck surgery: a systematic review and meta-analysis</article-title><source>Br J Oral Maxillofac Surg</source><year>2022</year><volume>60</volume><issue>10</issue><fpage>1292</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.1016/j.bjoms.2022.07.016</pub-id><pub-id pub-id-type="pmid">36328862</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Dawoud BES, Kent S, Tabbenor O, Markose G, Java K, Kyzas P. Does anticoagulation improve outcomes of microvascular free flap reconstruction following head and neck surgery: a systematic review and meta-analysis. Br J Oral Maxillofac Surg. 2022;60(10):1292&#x02013;302. 10.1016/j.bjoms.2022.07.016.<pub-id pub-id-type="pmid">36328862</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SA</given-names></name><name><surname>Roh</surname><given-names>JL</given-names></name><name><surname>Kim</surname><given-names>SB</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Nam</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name></person-group><article-title>Aspirin use and head and neck cancer survival: an observational study of 11,623 person-years follow-up</article-title><source>Int J Clin Oncol</source><year>2018</year><volume>23</volume><issue>1</issue><fpage>52</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1007/s10147-017-1165-3</pub-id><pub-id pub-id-type="pmid">28725937</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Kim SA, Roh JL, Kim SB, Choi SH, Nam SY, Kim SY. Aspirin use and head and neck cancer survival: an observational study of 11,623 person-years follow-up. Int J Clin Oncol. 2018;23(1):52&#x02013;8. 10.1007/s10147-017-1165-3.<pub-id pub-id-type="pmid">28725937</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Rothweiler</surname><given-names>R</given-names></name><name><surname>Gerlach</surname><given-names>V</given-names></name><name><surname>Voss</surname><given-names>P</given-names></name><etal/></person-group><article-title>Aspirin, heparin and ischemia time in microvascular free flap surgery - their influence and an optimal anticoagulation protocol</article-title><source>J Stomatol Oral Maxillofac Surg</source><year>2022</year><volume>123</volume><issue>5</issue><fpage>e556</fpage><lpage>e562</lpage><pub-id pub-id-type="doi">10.1016/j.jormas.2022.03.001</pub-id><pub-id pub-id-type="pmid">35272089</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Rothweiler R, Gerlach V, Voss P, et al. Aspirin, heparin and ischemia time in microvascular free flap surgery - their influence and an optimal anticoagulation protocol. J Stomatol Oral Maxillofac Surg. 2022;123(5):e556&#x02013;62. 10.1016/j.jormas.2022.03.001.<pub-id pub-id-type="pmid">35272089</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Sievert</surname><given-names>M</given-names></name><name><surname>Goncalves</surname><given-names>M</given-names></name><name><surname>Tamse</surname><given-names>R</given-names></name><etal/></person-group><article-title>Postoperative management of antithrombotic medication in microvascular head and neck reconstruction: a comparative analysis of unfractionated and low-molecular-weight heparin</article-title><source>Eur Arch Otorhinolaryngol</source><year>2021</year><volume>278</volume><issue>5</issue><fpage>1567</fpage><lpage>1575</lpage><pub-id pub-id-type="doi">10.1007/s00405-020-06219-w</pub-id><pub-id pub-id-type="pmid">32710177</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Sievert M, Goncalves M, Tamse R, et al. Postoperative management of antithrombotic medication in microvascular head and neck reconstruction: a comparative analysis of unfractionated and low-molecular-weight heparin. Eur Arch Otorhinolaryngol. 2021;278(5):1567&#x02013;75. 10.1007/s00405-020-06219-w.<pub-id pub-id-type="pmid">32710177</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Cannady</surname><given-names>SB</given-names></name><name><surname>Hatten</surname><given-names>K</given-names></name><name><surname>Wax</surname><given-names>MK</given-names></name></person-group><article-title>Postoperative Controversies in the Management of Free Flap Surgery in the Head and Neck</article-title><source>Facial Plast Surg Clin North Am</source><year>2016</year><volume>24</volume><issue>3</issue><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/j.fsc.2016.03.007</pub-id><pub-id pub-id-type="pmid">27400844</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Cannady SB, Hatten K, Wax MK. Postoperative Controversies in the Management of Free Flap Surgery in the Head and Neck. Facial Plast Surg Clin North Am. 2016;24(3):309&#x02013;14. 10.1016/j.fsc.2016.03.007.<pub-id pub-id-type="pmid">27400844</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>WB</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Are antithrombotic agents necessary for head and neck microvascular surgery?</article-title><source>Int J Oral Maxillofac Surg</source><year>2019</year><volume>48</volume><issue>7</issue><fpage>869</fpage><lpage>874</lpage><pub-id pub-id-type="doi">10.1016/j.ijom.2018.10.022</pub-id><pub-id pub-id-type="pmid">30497789</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Zhou W, Zhang WB, Yu Y, et al. Are antithrombotic agents necessary for head and neck microvascular surgery? Int J Oral Maxillofac Surg. 2019;48(7):869&#x02013;74. 10.1016/j.ijom.2018.10.022.<pub-id pub-id-type="pmid">30497789</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Kroll</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Reece</surname><given-names>G</given-names></name><etal/></person-group><article-title>Anticoagulants and hematomas in free flap surgery</article-title><source>Plast Reconstr Surg</source><year>1995</year><volume>96</volume><issue>3</issue><fpage>643</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1097/00006534-199509000-00017</pub-id><pub-id pub-id-type="pmid">7543686</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Kroll S, Miller M, Reece G, et al. Anticoagulants and hematomas in free flap surgery. Plast Reconstr Surg. 1995;96(3):643&#x02013;7. 10.1097/00006534-199509000-00017.<pub-id pub-id-type="pmid">7543686</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>M</given-names></name><name><surname>Badhey</surname><given-names>A</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Thromboprophylaxis in Head and Neck Microvascular Reconstruction</article-title><source>Craniomaxillofac Trauma Reconstr</source><year>2018</year><volume>11</volume><issue>2</issue><fpage>85</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1055/s-0037-1607068</pub-id><pub-id pub-id-type="pmid">29892322</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Abraham M, Badhey A, Hu S, et al. Thromboprophylaxis in Head and Neck Microvascular Reconstruction. Craniomaxillofac Trauma Reconstr. 2018;11(2):85&#x02013;95. 10.1055/s-0037-1607068.<pub-id pub-id-type="pmid">29892322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Huynh</surname><given-names>MNQ</given-names></name><name><surname>Bhagirath</surname><given-names>V</given-names></name><name><surname>Gupta</surname><given-names>M</given-names></name><name><surname>Avram</surname><given-names>R</given-names></name><name><surname>Cheung</surname><given-names>K</given-names></name></person-group><article-title>Multidisciplinary Practice Variations of Anti-Thrombotic Strategies for Free Tissue Transfers</article-title><source>Plastic Surgery</source><year>2022</year><volume>30</volume><issue>4</issue><fpage>343</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1177/22925503211024742</pub-id><pub-id pub-id-type="pmid">36212097</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Huynh MNQ, Bhagirath V, Gupta M, Avram R, Cheung K. Multidisciplinary Practice Variations of Anti-Thrombotic Strategies for Free Tissue Transfers. Plastic Surgery. 2022;30(4):343&#x02013;52. 10.1177/22925503211024742.<pub-id pub-id-type="pmid">36212097</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>TL</given-names></name><name><surname>Pumplin</surname><given-names>DW</given-names></name><name><surname>Holton</surname><given-names>LH</given-names></name><name><surname>Taylor</surname><given-names>JA</given-names></name><name><surname>Rodriguez</surname><given-names>ED</given-names></name><name><surname>Silverman</surname><given-names>RP</given-names></name></person-group><article-title>Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban</article-title><source>Plast Reconstr Surg</source><year>2007</year><volume>120</volume><issue>5</issue><fpage>1281</fpage><lpage>1288</lpage><pub-id pub-id-type="doi">10.1097/01.PRS.0000279327.75083.AE</pub-id><pub-id pub-id-type="pmid">17898601</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Chung TL, Pumplin DW, Holton LH, Taylor JA, Rodriguez ED, Silverman RP. Prevention of microsurgical anastomotic thrombosis using aspirin, heparin, and the glycoprotein IIb/IIIa inhibitor tirofiban. Plast Reconstr Surg. 2007;120(5):1281&#x02013;8. 10.1097/01.PRS.0000279327.75083.AE.<pub-id pub-id-type="pmid">17898601</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Lighthall</surname><given-names>JG</given-names></name><name><surname>Cain</surname><given-names>R</given-names></name><name><surname>Ghanem</surname><given-names>TA</given-names></name><name><surname>Wax</surname><given-names>MK</given-names></name></person-group><article-title>Effect of postoperative aspirin on outcomes in microvascular free tissue transfer surgery</article-title><source>Otolaryngology - Head and Neck Surgery (United States)</source><year>2013</year><volume>148</volume><issue>1</issue><fpage>40</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1177/0194599812463320</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Lighthall JG, Cain R, Ghanem TA, Wax MK. Effect of postoperative aspirin on outcomes in microvascular free tissue transfer surgery. Otolaryngology - Head and Neck Surgery (United States). 2013;148(1):40&#x02013;6. 10.1177/0194599812463320.</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>SA</given-names></name><name><surname>Tayeb</surname><given-names>RK</given-names></name></person-group><article-title>Postoperative outcomes of aspirin in microvascular free tissue transfer surgery&#x02014;A systematic review and meta-analysis</article-title><source>JPRAS Open</source><year>2024</year><volume>39</volume><fpage>49</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.jpra.2023.11.003</pub-id><pub-id pub-id-type="pmid">38162533</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Khan SA, Tayeb RK. Postoperative outcomes of aspirin in microvascular free tissue transfer surgery&#x02014;A systematic review and meta-analysis. JPRAS Open. 2024;39:49&#x02013;59. 10.1016/j.jpra.2023.11.003.<pub-id pub-id-type="pmid">38162533</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Numajiri</surname><given-names>T</given-names></name><name><surname>Sowa</surname><given-names>Y</given-names></name><name><surname>Nishino</surname><given-names>K</given-names></name><etal/></person-group><article-title>Use of systemic low-dose unfractionated heparin in microvascular head and neck reconstruction: Influence in free-flap outcomes</article-title><source>J Plast Surg Hand Surg</source><year>2016</year><volume>50</volume><issue>3</issue><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.3109/2000656X.2015.1125359</pub-id><pub-id pub-id-type="pmid">26937948</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Numajiri T, Sowa Y, Nishino K, et al. Use of systemic low-dose unfractionated heparin in microvascular head and neck reconstruction: Influence in free-flap outcomes. J Plast Surg Hand Surg. 2016;50(3):135&#x02013;41. 10.3109/2000656X.2015.1125359.<pub-id pub-id-type="pmid">26937948</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Crawley</surname><given-names>MB</given-names></name><name><surname>Sweeny</surname><given-names>L</given-names></name><name><surname>Ravipati</surname><given-names>P</given-names></name><etal/></person-group><article-title>Factors Associated with Free Flap Failures in Head and Neck Reconstruction</article-title><source>Otolaryngology - Head and Neck Surgery (United States)</source><year>2019</year><volume>161</volume><issue>4</issue><fpage>598</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1177/0194599819860809</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Crawley MB, Sweeny L, Ravipati P, et al. Factors Associated with Free Flap Failures in Head and Neck Reconstruction. Otolaryngology - Head and Neck Surgery (United States). 2019;161(4):598&#x02013;604. 10.1177/0194599819860809.</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>KY</given-names></name><name><surname>Lin</surname><given-names>YS</given-names></name><name><surname>Chen</surname><given-names>LW</given-names></name><name><surname>Yang</surname><given-names>KC</given-names></name><name><surname>Huang</surname><given-names>WC</given-names></name><name><surname>Liu</surname><given-names>WC</given-names></name></person-group><article-title>Risk of Free Flap Failure in Head and Neck Reconstruction: Analysis of 21,548 Cases From A Nationwide Database</article-title><source>Ann Plast Surg</source><year>2020</year><volume>84</volume><issue>1</issue><fpage>S3</fpage><lpage>S6</lpage><pub-id pub-id-type="doi">10.1097/SAP.0000000000002180</pub-id><pub-id pub-id-type="pmid">31833882</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Wang KY, Lin YS, Chen LW, Yang KC, Huang WC, Liu WC. Risk of Free Flap Failure in Head and Neck Reconstruction: Analysis of 21,548 Cases From A Nationwide Database. Ann Plast Surg. 2020;84(1):S3&#x02013;6. 10.1097/SAP.0000000000002180.<pub-id pub-id-type="pmid">31833882</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Bonapace-Potvin</surname><given-names>M</given-names></name><name><surname>Govshievich</surname><given-names>A</given-names></name><name><surname>Tessier</surname><given-names>L</given-names></name><name><surname>Karunanayake</surname><given-names>M</given-names></name><name><surname>Tremblay</surname><given-names>D</given-names></name><name><surname>Chollet</surname><given-names>A</given-names></name></person-group><article-title>Canadian Trends in Free Flap Management for Microsurgical Lower Limb Reconstruction</article-title><source>Plastic Surgery</source><year>2023</year><volume>31</volume><issue>1</issue><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1177/22925503211019602</pub-id><pub-id pub-id-type="pmid">36755829</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Bonapace-Potvin M, Govshievich A, Tessier L, Karunanayake M, Tremblay D, Chollet A. Canadian Trends in Free Flap Management for Microsurgical Lower Limb Reconstruction. Plastic Surgery. 2023;31(1):70&#x02013;7. 10.1177/22925503211019602.<pub-id pub-id-type="pmid">36755829</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>SY</given-names></name><name><surname>Huang</surname><given-names>JJ</given-names></name><name><surname>Tsao</surname><given-names>CK</given-names></name><etal/></person-group><article-title>Does ischemia time affect the outcome of free fibula flaps for head and neck reconstruction? A review of 116 cases</article-title><source>Plast Reconstr Surg</source><year>2010</year><volume>126</volume><issue>6</issue><fpage>1988</fpage><lpage>1995</lpage><pub-id pub-id-type="doi">10.1097/PRS.0B013E3181F448C8</pub-id><pub-id pub-id-type="pmid">21124137</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Chang SY, Huang JJ, Tsao CK, et al. Does ischemia time affect the outcome of free fibula flaps for head and neck reconstruction? A review of 116 cases. Plast Reconstr Surg. 2010;126(6):1988&#x02013;95. 10.1097/PRS.0B013E3181F448C8.<pub-id pub-id-type="pmid">21124137</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Fichter</surname><given-names>AM</given-names></name><name><surname>Ritschl</surname><given-names>LM</given-names></name><name><surname>Rau</surname><given-names>A</given-names></name><etal/></person-group><article-title>Free flap rescue using an extracorporeal perfusion device</article-title><source>Journal of Cranio-Maxillofacial Surgery</source><year>2016</year><volume>44</volume><issue>12</issue><fpage>1889</fpage><lpage>1895</lpage><pub-id pub-id-type="doi">10.1016/j.jcms.2016.09.010</pub-id><pub-id pub-id-type="pmid">27756552</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Fichter AM, Ritschl LM, Rau A, et al. Free flap rescue using an extracorporeal perfusion device. Journal of Cranio-Maxillofacial Surgery. 2016;44(12):1889&#x02013;95. 10.1016/j.jcms.2016.09.010.<pub-id pub-id-type="pmid">27756552</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Forner</surname><given-names>D</given-names></name><name><surname>Williams</surname><given-names>BA</given-names></name><name><surname>Makki</surname><given-names>FM</given-names></name><name><surname>Trites</surname><given-names>JR</given-names></name><name><surname>Taylor</surname><given-names>SM</given-names></name><name><surname>Hart</surname><given-names>RD</given-names></name></person-group><article-title>Late free flap failure in head and neck reconstruction: A systematic review</article-title><source>Ear Nose Throat J</source><year>2018</year><volume>97</volume><issue>7</issue><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1177/014556131809700712</pub-id><pub-id pub-id-type="pmid">30036435</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Forner D, Williams BA, Makki FM, Trites JR, Taylor SM, Hart RD. Late free flap failure in head and neck reconstruction: A systematic review. Ear Nose Throat J. 2018;97(7):213&#x02013;6. 10.1177/014556131809700712.<pub-id pub-id-type="pmid">30036435</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Novakovic</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>RS</given-names></name><name><surname>Goldstein</surname><given-names>DP</given-names></name><name><surname>Gullane</surname><given-names>PJ</given-names></name></person-group><article-title>Salvage of failed free flaps used in head and neck reconstruction</article-title><source>Head Neck Oncol</source><year>2009</year><volume>1</volume><fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1758-3284-1-33</pub-id><pub-id pub-id-type="pmid">19698095</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Novakovic D, Patel RS, Goldstein DP, Gullane PJ. Salvage of failed free flaps used in head and neck reconstruction. Head Neck Oncol. 2009;1:33. 10.1186/1758-3284-1-33.<pub-id pub-id-type="pmid">19698095</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>MY</given-names></name><name><surname>Shin</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>YK</given-names></name><name><surname>Sabbagh</surname><given-names>MD</given-names></name><name><surname>Roh</surname><given-names>SG</given-names></name><name><surname>Lee</surname><given-names>NH</given-names></name></person-group><article-title>Does Low-Dose Heparin Have a Significant Role in Free Flap Surgery?</article-title><source>Arch Craniofac Surg</source><year>2017</year><volume>18</volume><issue>3</issue><fpage>162</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.7181/ACFS.2017.18.3.162</pub-id><pub-id pub-id-type="pmid">29090196</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">An MY, Shin JY, Lee YK, Sabbagh MD, Roh SG, Lee NH. Does Low-Dose Heparin Have a Significant Role in Free Flap Surgery? Arch Craniofac Surg. 2017;18(3):162&#x02013;5. 10.7181/ACFS.2017.18.3.162.<pub-id pub-id-type="pmid">29090196</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>EH</given-names></name><name><surname>Bauder</surname><given-names>AR</given-names></name><name><surname>Centkowski</surname><given-names>S</given-names></name><etal/></person-group><article-title>Preoperative Platelet Count Predicts Lower Extremity Free Flap Thrombosis: A Multi-Institutional Experience</article-title><source>Plast Reconstr Surg</source><year>2017</year><volume>139</volume><issue>1</issue><fpage>220</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.1097/PRS.0000000000002893</pub-id><pub-id pub-id-type="pmid">27632402</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Cho EH, Bauder AR, Centkowski S, et al. Preoperative Platelet Count Predicts Lower Extremity Free Flap Thrombosis: A Multi-Institutional Experience. Plast Reconstr Surg. 2017;139(1):220&#x02013;30. 10.1097/PRS.0000000000002893.<pub-id pub-id-type="pmid">27632402</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Kalmar</surname><given-names>CL</given-names></name><name><surname>Drolet</surname><given-names>BC</given-names></name><name><surname>Kassis</surname><given-names>S</given-names></name><name><surname>Thayer</surname><given-names>WP</given-names></name><name><surname>Higdon</surname><given-names>KK</given-names></name><name><surname>Perdikis</surname><given-names>G</given-names></name></person-group><article-title>Breast Reconstruction Free Flap Failure: Does Platelet Count Matter?</article-title><source>Ann Plast Surg</source><year>2022</year><volume>89</volume><issue>5</issue><fpage>523</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1097/SAP.0000000000003269</pub-id><pub-id pub-id-type="pmid">36279577</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Kalmar CL, Drolet BC, Kassis S, Thayer WP, Higdon KK, Perdikis G. Breast Reconstruction Free Flap Failure: Does Platelet Count Matter? Ann Plast Surg. 2022;89(5):523&#x02013;8. 10.1097/SAP.0000000000003269.<pub-id pub-id-type="pmid">36279577</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Wax</surname><given-names>MK</given-names></name><name><surname>Azzi</surname><given-names>J</given-names></name></person-group><article-title>Perioperative considerations in free flap surgery: A review of pressors and anticoagulation</article-title><source>Oral Oncol</source><year>2018</year><volume>83</volume><fpage>154</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.oraloncology.2018.06.025</pub-id><pub-id pub-id-type="pmid">30098772</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Wax MK, Azzi J. Perioperative considerations in free flap surgery: A review of pressors and anticoagulation. Oral Oncol. 2018;83:154&#x02013;7. 10.1016/j.oraloncology.2018.06.025.<pub-id pub-id-type="pmid">30098772</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Wax MK. The role of the implantable Doppler probe in free flap surgery. Laryngoscope. 2014;124(S1). 10.1002/lary.24569</mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Zinser MJ, Kr&#x000f6;ger N, Malter W, et al. Preoperative Perforator Mapping in DIEP Flaps for Breast Reconstruction. The Impact of New Contrast-Enhanced Ultrasound Techniques. J Pers Med. 2022;13(1). 10.3390/JPM13010064</mixed-citation></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Heneweer</surname><given-names>C</given-names></name><name><surname>Zirk</surname><given-names>M</given-names></name><name><surname>Safi</surname><given-names>A</given-names></name><etal/></person-group><article-title>An Innovative Approach for Preoperative Perforator Flap Planning Using Contrast-enhanced B-flow Imaging</article-title><source>Plast Reconstr Surg Glob Open</source><year>2021</year><volume>9</volume><issue>5</issue><fpage>E3547</fpage><pub-id pub-id-type="doi">10.1097/GOX.0000000000003547</pub-id><pub-id pub-id-type="pmid">34036019</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Heneweer C, Zirk M, Safi A, et al. An Innovative Approach for Preoperative Perforator Flap Planning Using Contrast-enhanced B-flow Imaging. Plast Reconstr Surg Glob Open. 2021;9(5):E3547. 10.1097/GOX.0000000000003547.<pub-id pub-id-type="pmid">34036019</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname><given-names>CSL</given-names></name><name><surname>Kok</surname><given-names>YO</given-names></name><name><surname>Yong</surname><given-names>CPC</given-names></name><etal/></person-group><article-title>Outcome predictors in elderly head and neck free flap reconstruction: A retrospective study and systematic review of the current evidence</article-title><source>J Plast Reconstr Aesthet Surg</source><year>2018</year><volume>71</volume><issue>5</issue><fpage>719</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1016/J.BJPS.2017.12.011</pub-id><pub-id pub-id-type="pmid">29290568</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Goh CSL, Kok YO, Yong CPC, et al. Outcome predictors in elderly head and neck free flap reconstruction: A retrospective study and systematic review of the current evidence. J Plast Reconstr Aesthet Surg. 2018;71(5):719&#x02013;28. 10.1016/J.BJPS.2017.12.011.<pub-id pub-id-type="pmid">29290568</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>